Loading...
Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
Estrogen receptor modulators and estrogen deprivation have become standards of care for hormone receptor–positive metastatic breast cancer. However, after traditional first-line endocrine monotherapy treatment, the disease typically progresses despite the initial high rate of clinical benefit. Multi...
Saved in:
| Published in: | Curr Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Multimed Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001771/ https://ncbi.nlm.nih.gov/pubmed/29910656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.4000 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|